TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18085432

Group type: EXPERIMENTAL
Intervention: Directly administered antiretroviral therapy (DAART)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Self‐administered therapy (SAT)
Number of subjects: 141
Study: 16157524

Group type: EXPERIMENTAL
Intervention: Resting myocardial perfusion heterogeneity quantified by Markovian homogeneity analysis
Number of subjects: 1084

Group type: EXPERIMENTAL
Intervention: Improvement during dipyridamole stress
Number of subjects: 1084

Group type: EXPERIMENTAL
Intervention: Resting homogeneity index outside 1 SD of healthy reference subjects
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Standard risk factors
Number of subjects: 1084
Study: 12611611

Group type: EXPERIMENTAL
Intervention: Selenium status
Number of subjects: 1900

Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 1900
Study: 10960901

Group type: EXPERIMENTAL
Intervention: Massage with essential oils (aromatherapy)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Massage only (control group)
Number of subjects: 8
Study: 8750423

Group type: EXPERIMENTAL
Intervention: Intentions regarding sexual intercourse in the next half-year
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Youth who thought it likely they would be sexually-active in the next 6 months
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Intentions regarding future coitus among sexually-experienced youth at baseline
Number of subjects: 119
Study: 1408571

Group type: EXPERIMENTAL
Intervention: Oral antimicrobial agents
Number of subjects: 279

Group type: COMPARATOR
Intervention: Parenteral antibiotics
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Change from parenteral to oral antibiotics
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 279
Study: 3913756

Group type: EXPERIMENTAL
Intervention: Clonidine (75-300 micrograms daily)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 3578614

Group type: EXPERIMENTAL
Intervention: Case management services (E group, N = 213)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Usual and customary services (C group, N = 204)
Number of subjects: 417
Study: 29392280

Group type: EXPERIMENTAL
Intervention: TTFields therapy
Number of subjects: 695

Group type: COMPARATOR
Intervention: Temozolomide alone
Number of subjects: 695
Study: 27059152

Group type: EXPERIMENTAL
Intervention: Endovascular repair (EVAR)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Open repair
Number of subjects: 351

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 351
Study: 24938404

Group type: EXPERIMENTAL
Intervention: Morning cortisol levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circadian modulation
Number of subjects: 0
Study: 23422605

Group type: EXPERIMENTAL
Intervention: Calcium (500 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetaminophen (325 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Calcium vs Acetaminophen
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Calcium
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 20389249

Group type: EXPERIMENTAL
Intervention: n-3 PUFA supplementation (2.4 g)
Number of subjects: 563

Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 563
Study: 17968030

Group type: EXPERIMENTAL
Intervention: special education program (clinical index group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: follow‐up without the special education program (clinical comparison group)
Number of subjects: 60
Study: 16179955

Group type: EXPERIMENTAL
Intervention: Meptin DPI (20 mcg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Meptin MDI (20 mcg)
Number of subjects: 16
Study: 12543895

Group type: EXPERIMENTAL
Intervention: Radiocephalic AVF creation with surgical and interventional treatment
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Interventions (PTA and surgery) for non-functioning RCAVFs
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Functioning AVFs blood flow measurement
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Final functional status of RCAVFs
Number of subjects: 43
Study: 10869893

Group type: EXPERIMENTAL
Intervention: 10% Lipofundin MCT/LCT (1.5 g. kg. d)
Number of subjects: 38

Group type: COMPARATOR
Intervention: 10% LCT (1.5 g. kg. d)
Number of subjects: 38
Study: 8937319

Group type: COMPARATOR
Intervention: Conventional spin-echo (CSE)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fast spin-echo (FSE)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Overall preference
Number of subjects: 29

Group type: COMPARATOR
Intervention: Artefact level
Number of subjects: 29
Study: 1547922

Group type: EXPERIMENTAL
Intervention: Linoleic-acid-enriched diet (n = 16 after dropouts)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual diet (n = 20)
Number of subjects: 38
Study: 3157666

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (45 Gy)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation (45 Gy)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Surgery only (Control)
Number of subjects: 138
Study: 29059349

Group type: EXPERIMENTAL
Intervention: Elastic net proportional hazards regression model
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Backward elimination model
Number of subjects: 92
Study: 30573210

Group type: EXPERIMENTAL
Intervention: Cisatracurium stored at room temperature
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 26892713

Group type: EXPERIMENTAL
Intervention: Low-pressure CO2 pneumoperitoneum
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard-pressure CO2 pneumoperitoneum
Number of subjects: 50
Study: 25040325

Group type: EXPERIMENTAL
Intervention: Twice-daily application of a commercially available, standardised pH neutral, perfume-free moisturiser on extremities.
Number of subjects: 424

Group type: COMPARATOR
Intervention: Ad hoc or no standardised skin-moisturising regimen (Control).
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Twice-daily application of moisturiser.
Number of subjects: 424
Study: 21636189

Group type: EXPERIMENTAL
Intervention: Sutureless wound closure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Multiple-suture closure
Number of subjects: 30
Study: 20457972

Group type: EXPERIMENTAL
Intervention: Single-session pattern scanning laser panretinal photocoagulation (SS-PRP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Multiple-session single-spot panretinal photocoagulation (MS-PRP)
Number of subjects: 40
Study: 17661240

Group type: EXPERIMENTAL
Intervention: COPD outpatient education programme (ATEM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard therapy (control)
Number of subjects: 50
Study: 16118757

Group type: EXPERIMENTAL
Intervention: Mental walking training
Number of subjects: 24

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 24
Study: 12360554

Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-10 mg/day to effect)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11012909

Group type: EXPERIMENTAL
Intervention: RF-bic
Number of subjects: 117
Study: 8831640

Group type: EXPERIMENTAL
Intervention: Educational review group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-session group
Number of subjects: 0

Group type: COMPARATOR
Intervention: No review (single-session group)
Number of subjects: 0
Study: 1575056

Group type: EXPERIMENTAL
Intervention: nHuIFN-alpha and nHuTNF-alpha combination (10 micrograms of nHuIFN-alpha and 3 micrograms of nHuTNF-alpha) injected intravenously at a maintenance dose of more than 2 x 10(6)U/day for over 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: nHuIFN-alpha and nHuTNF-alpha combination at a maintenance dose of 1 x 10(6)U/day
Number of subjects: 120
Study: 3906426

Group type: EXPERIMENTAL
Intervention: Tiapride (600 mg/day)
Number of subjects: 21
Study: 31889572

Group type: EXPERIMENTAL
Intervention: Gum chewing during IV cannulation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 73
Study: 31228455

Group type: EXPERIMENTAL
Intervention: Curcumin (480 mg nanomicelle curcumin orally)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (standard treatment only)
Number of subjects: 110
Study: 29354951

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Chinese medicine of artificial cycle therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Letrozole and metformin (control group)
Number of subjects: 60
Study: 25391329

Group type: EXPERIMENTAL
Intervention: Feedback intervention (6 feedback sessions with visual feedback during 2-point discrimination training and pelvic tilting)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (6 sessions of physiotherapy, relaxation training, and movement training)
Number of subjects: 30
Study: 24219633

Group type: EXPERIMENTAL
Intervention: KUB&CT
Number of subjects: 154

Group type: COMPARATOR
Intervention: CT
Number of subjects: 154
Study: 21515027

Group type: EXPERIMENTAL
Intervention: Virtual reality exposure therapy (VRE)
Number of subjects: 41
Study: 17698219

Group type: EXPERIMENTAL
Intervention: Standardized protocol for evaluation during phase II
Number of subjects: 1725

Group type: COMPARATOR
Intervention: Control evaluation during phase II
Number of subjects: 1725
Study: 16432600

Group type: EXPERIMENTAL
Intervention: 2% tea lotion applied twice daily for 2 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 60
Study: 12891305

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not receiving lipid lowering drugs)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 90
Study: 10618570

Group type: EXPERIMENTAL
Intervention: Panel readings by 3 experienced angiographers
Number of subjects: 308
Study: 9252084

Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Elective sclerotherapy
Number of subjects: 24
Study: 8302982

Group type: EXPERIMENTAL
Intervention: Nicotine fading and cigarette fading
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Nicotine fading and concurrent smokeholding
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Nicotine fading and subsequent smokeholding
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Nonintensive smokeholding programme
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Intensive smokeholding programme (daily sessions)
Number of subjects: 73
Study: 3574823

Group type: EXPERIMENTAL
Intervention: 2.5 mg medroxyprogesterone acetate for days 1-28
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 5 mg medroxyprogesterone acetate for days 1-28
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 5 mg medroxyprogesterone acetate for days 17-28
Number of subjects: 3
Study: 28144795

Group type: EXPERIMENTAL
Intervention: 2.8-mm clear corneal incision
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 2.2-mm clear corneal incision
Number of subjects: 140

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 140
Study: 28508344

Group type: EXPERIMENTAL
Intervention: Vaginal hysterectomy (VH)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 50
Study: 25679228

Group type: EXPERIMENTAL
Intervention: Internet intervention 'Mastery over Dementia'
Number of subjects: 251

Group type: COMPARATOR
Intervention: Minimal intervention consisting of e‐bulletins
Number of subjects: 251
Study: 23608658

Group type: COMPARATOR
Intervention: Sodium Repletion (SR)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sodium Depletion (SD)
Number of subjects: 64
Study: 21126856

Group type: EXPERIMENTAL
Intervention: Inotropic contractile reserve (ICR) assessed by low-dose dobutamine stress echocardiography
Number of subjects: 54

Group type: COMPARATOR
Intervention: Dyssynchrony
Number of subjects: 54

Group type: COMPARATOR
Intervention: QRS duration
Number of subjects: 54
Study: 18068146

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 1092
Study: 17203530

Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole
Number of subjects: 211

Group type: COMPARATOR
Intervention: Oral omeprazole
Number of subjects: 211
Study: 12717129

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60
Study: 10890580

Group type: EXPERIMENTAL
Intervention: Macorel tablets (test preparation)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Adalat tablets (reference preparation)
Number of subjects: 18
Study: 8956918

Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB) continued for 2 months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (VGB stopped for 3 weeks)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB) continued
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (VGB stopped)
Number of subjects: 28
Study: 8040124

Group type: EXPERIMENTAL
Intervention: Amphotericin B in 5% dextrose
Number of subjects: 42

Group type: COMPARATOR
Intervention: Amphotericin B in Intralipid
Number of subjects: 42
Study: 2742790

Group type: EXPERIMENTAL
Intervention: Small group discussions
Number of subjects: 70

Group type: COMPARATOR
Intervention: Large lecture group
Number of subjects: 70
Study: 31064021

Group type: EXPERIMENTAL
Intervention: Medial pivot (MP) implant
Number of subjects: 100

Group type: COMPARATOR
Intervention: Posterior cruciate ligament (PCL) substitution (posterior‐stabilized [PS]) prosthesis
Number of subjects: 100
Study: 31389278

Group type: EXPERIMENTAL
Intervention: Daily rhythm of distal skin temperature (DST)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Mean DST during 10 consecutive hours of minimum values
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Interday stability of DST
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Intraday variability of DST
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Exposure to lowest ambient temperature
Number of subjects: 77
Study: 28597102

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) + Weight Loss (WL)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Weight Loss (WL) alone
Number of subjects: 36
Study: 25078334

Group type: EXPERIMENTAL
Intervention: Brodalumab (antibody to interleukin-17 receptor A)
Number of subjects: 0
Study: 23494471

Group type: EXPERIMENTAL
Intervention: Mendelsohn maneuver
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 18
Study: 21755537

Group type: EXPERIMENTAL
Intervention: IPX066
Number of subjects: 27

Group type: COMPARATOR
Intervention: Immediate-release carbidopa-levodopa
Number of subjects: 27
Study: 19284929

Group type: EXPERIMENTAL
Intervention: Group psychoeducation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Unstructured group support (Control)
Number of subjects: 120
Study: 17539888

Group type: EXPERIMENTAL
Intervention: 4-h training programme in 'hands off' positioning and attachment support
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (student midwives)
Number of subjects: 135
Study: 15121740

Group type: EXPERIMENTAL
Intervention: Young fit (YF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Young unfit (YU)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Older fit (OF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Older unfit (OU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: LBNP tolerance
Number of subjects: 40
Study: 11176158

Group type: EXPERIMENTAL
Intervention: Extended end-inspiratory pause (EIP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 0.2 secs EIP
Number of subjects: 16
Study: 9508522

Group type: EXPERIMENTAL
Intervention: 200 mg of erythromycin during fasting state
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 mg of erythromycin plus 300 ml of fresh milk (postprandial state)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 300 ml of fresh milk and normal saline as placebo (postprandial state)
Number of subjects: 10
Study: 7564304

Group type: EXPERIMENTAL
Intervention: Sociopolitical stressors (recurring and continuous)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Personal stressors (undesirable life changes)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Adverse sociopolitical conditions
Number of subjects: 100

Group type: COMPARATOR
Intervention: Personal nature stressors
Number of subjects: 100
Study: 2266755

Group type: EXPERIMENTAL
Intervention: Group A (exercise at 15% below VT for 12 minutes)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Group B (exercise at 15% above VT for 12 minutes)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Both groups (collapsed means)
Number of subjects: 11
Study: 7395780

Group type: EXPERIMENTAL
Intervention: Intravenous supplements of essential or essential and nonessential amino acids for 2 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nutritional assessment using anthropometric measurements, serum protein content, immune response, and dietary intake diaries
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dietary intake of nutrients with dietary diaries
Number of subjects: 0
Study: 31774510

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) + Radial Extracorporeal Shock Wave Therapy (rESWT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 40
Study: 30910662

Group type: EXPERIMENTAL
Intervention: Shared Medical Appointments (SMA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional Appointments
Number of subjects: 0
Study: 27091469

Group type: EXPERIMENTAL
Intervention: Voice rehabilitation (19 patients)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (23 patients)
Number of subjects: 42
Study: 26008632

Group type: EXPERIMENTAL
Intervention: Diagnostic imaging (radiologic studies)
Number of subjects: 30
Study: 24000594

Group type: EXPERIMENTAL
Intervention: Polysaccharide 23-valent pneumococcus vaccine (Pneumo 23, Sanofi Pasteur, France)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (not immunized against pneumococcus infection)
Number of subjects: 200
Study: 21715653

Group type: EXPERIMENTAL
Intervention: Brief structured diabetes education programme
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 164
Study: 19232899

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily for 1 to 8 weeks
Number of subjects: 48
Study: 16433794

Group type: EXPERIMENTAL
Intervention: Aspirin challenge test in family 1
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Aspirin challenge test in family 2
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Variant LTC4S genotype in family 1
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Variant LTC4S genotype in family 2
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: GSTM1 gene deletion in both families
Number of subjects: 74
Study: 12605339

Group type: EXPERIMENTAL
Intervention: Computer-assisted navigation system (CAS) for acetabular implant positioning
Number of subjects: 100
Study: 14622610

Group type: EXPERIMENTAL
Intervention: 30% sucrose
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 10% glucose
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 30% glucose
Number of subjects: 113

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 113
Study: 1831908

Group type: EXPERIMENTAL
Intervention: RU 41 656 (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Triazolam (0.25 mg)
Number of subjects: 12
Study: 6616310

Group type: EXPERIMENTAL
Intervention: Hyperproteic diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hyperlipidic-normoproteic diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hyperglucidic diet
Number of subjects: 24
Study: 29672184

Group type: EXPERIMENTAL
Intervention: Amino acid supplement (3g HMB, 14g arginine, 14g glutamine)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 29742967

Group type: EXPERIMENTAL
Intervention: Restrictive fluid therapy
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Liberal fluid therapy
Number of subjects: 3000
Study: 26521887

Group type: COMPARATOR
Intervention: hs-CRP levels > 3 mg/L
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NLR
Number of subjects: 100
Study: 25315149

Group type: EXPERIMENTAL
Intervention: Core decompression + autologous bone graft with bone marrow buffy coat (BBC)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Core decompression + autologous bone graft
Number of subjects: 45
Study: 22545386

Group type: EXPERIMENTAL
Intervention: Nasal packing (NP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nasal septal suture (NSS)
Number of subjects: 60
Study: 20202625

Group type: EXPERIMENTAL
Intervention: Alcohol (0.4 g/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 g/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol (low dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol (high dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16919477

Group type: EXPERIMENTAL
Intervention: Non-arrow shapes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Arrows
Number of subjects: 0
Study: 16088018

Group type: EXPERIMENTAL
Intervention: Public insurance
Number of subjects: 1452

Group type: EXPERIMENTAL
Intervention: No insurance
Number of subjects: 1452

Group type: COMPARATOR
Intervention: Private insurance
Number of subjects: 1452
Study: 12235578

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Parent training
Number of subjects: 24
Study: 10638391

Group type: EXPERIMENTAL
Intervention: 60 mg oral dose of YM087
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 50 mg i.v. dose of YM087
Number of subjects: 6
Study: 7718321

Group type: EXPERIMENTAL
Intervention: Routine intravenous magnesium supplements
Number of subjects: 32

Group type: COMPARATOR
Intervention: Magnesium given on an 'as required' basis
Number of subjects: 32